Stockreport

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF LEXINGTON, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company foc [Read more]